In recent years, the field of artificial intelligence technology has been receiving much attention. On the one hand, it is indeed that artificial intelligence technology has unique advantages. Its powerful learning ability and intelligent reaction ability are quite welcome. For example, the famous Go event-AlphaGo defeated the world’s Go game. One person, Ke Jie; on the other hand, artificial intelligence technology is maturing, and has made great breakthroughs in many aspects. Artificial intelligence technology has blossomed in services, finance, manufacturing and other industries, and the field of biomedicine has also ushered in artificial intelligence. The east wind awakens the green life.

Artificial intelligence biotechnology, covering the entire field of biomedicine

The application of artificial intelligence technology in the field of biomedicine covers everything from the development of new drugs at the source to biopharmaceuticals to clinical trials. In the past, many examinations and diagnosis were based on microscope observation and doctors’ clinical experience. In the face of artificial intelligence, all doctors are likely to be “newcomers”. According to reports, at a meeting in Changsha, artificial intelligence technology and 200 top domestic doctors conducted a PK. As a result, the judgment accuracy of artificial intelligence reached 100%. What is even more amazing is that it takes less than 5 seconds. It is impossible for any famous doctor. In fact, an artificial intelligence system once learned 80 million cases, such a “full stomach economy”, and this is a doctor can’t do it all his life.

Artificial intelligence biotechnology revolutionizes the face of biomedicine

Clinical trials are the foothold of biomedicine, and new drug development is the leader in biomedicine. The development of new drugs is a top priority in the field of biomedicine, but in addition to the relatively closed nature of the new drugs, they also lack a lot of learning resources to support the use of artificial intelligence biotechnology. It is true that artificial intelligence biotechnology still needs to go a long way to revolutionize the face of biomedicine, but there are already companies at home and abroad that have taken steps forward.

Since 2017, international pharmaceutical giants have deployed their own AI systems to improve the research and development efficiency of new drugs, such as Merck, Novatis, Roche, Pfizer, Johnson & Johnsone, etc. Dawan Bio’s Klone4.0 and other technical service platforms combine artificial intelligence with biomedicine to make cell line development easier and more efficient.

As we all know, the development of new drugs has always been a long-term work. The spring breeze of artificial intelligence and biotechnology has transformed the development of new drugs from traditional labor-intensive to intelligent technology. In a limited cycle, unlimited possibilities can be created.

Technology is the first productive force. As the application of artificial intelligence technology matures, the biomedical field is not just about the air vent, it is likely to be an ecological innovation in the entire industry. From a macro perspective, it can be applied to almost all links of the entire industrial chain from new drug development, drug production, and clinical trials; from a micro perspective, artificial intelligence technology is used in a certain step of a new drug development, The entire new drug development efficiency is likely to increase exponentially.